Search Filters

Search Results

Found 1 results

510(k) Data Aggregation

    K Number
    K071079
    Manufacturer
    Date Cleared
    2007-08-02

    (107 days)

    Product Code
    Regulation Number
    N/A
    Reference & Predicate Devices
    N/A
    Why did this record match?
    Applicant Name (Manufacturer) :

    GAMBRO BCT, INC.

    AI/MLSaMDIVD (In Vitro Diagnostic)TherapeuticDiagnosticis PCCP AuthorizedThirdpartyExpeditedreview
    Intended Use

    The Spectra Optia Apheresis System, a blood component separator, is intended for use in therapeutic plasma exchange.

    Device Description

    Spectra Optia Apheresis System, a blood component separator

    AI/ML Overview

    This document is a 510(k) clearance letter from the FDA for the Spectra Optia Apheresis System. It states that the device is substantially equivalent to legally marketed predicate devices for use in therapeutic plasma exchange.

    However, the provided text does not contain any information about acceptance criteria or specific study data that proves the device meets such criteria. The letter is a regulatory approval document and not a performance study report.

    Therefore, I cannot fulfill your request for:

    1. A table of acceptance criteria and reported device performance.
    2. Sample sizes or data provenance.
    3. Number and qualifications of experts for ground truth.
    4. Adjudication method.
    5. Multi-reader multi-case (MRMC) comparative effectiveness study information.
    6. Standalone algorithm performance.
    7. Type of ground truth used.
    8. Training set sample size.
    9. How ground truth for the training set was established.

    The document only confirms the FDA's concurrence with the stated Indications for Use.

    Ask a Question

    Ask a specific question about this device

    Page 1 of 1